Groundbreaking Discovery in Lupus Research Reveals Potential Cure
Groundbreaking discovery in lupus research reveals a molecular defect driving the pathologic immune response in systemic lupus erythematosus. Reversing this defect could potentially lead to a cure for the disease, offering hope for over 1.5 million affected individuals in the US. Current treatments for lupus fall short, but researchers have identified a specific cause that may mitigate side effects associated with existing therapies. By targeting key mediators, the team aims to suppress the autoimmune response imbalance in lupus patients, unveiling a novel pathway for potential future treatments.
FDA Approves New Drug Iqirvo for Autoimmune Liver Disease Treatment
The FDA has approved a new drug, Iqirvo (elafibranor), for treating autoimmune liver disease, specifically primary biliary cholangitis (PBC). PBC can lead to liver damage or failure if left untreated, making early detection crucial. Iqirvo offers a targeted therapeutic approach to manage PBC and prevent complications, marking a significant advancement in autoimmune liver disease treatment.
Managing Lupus Symptoms
May is Lupus Awareness Month, highlighting the challenges faced by the 1.5 million Americans living with this chronic autoimmune disease. Learn about the importance of managing lupus symptoms, the impact of weight on symptom severity, and key strategies recommended by the Lupus Foundation of America for improved well-being.
Milwaukee Landmarks Illuminate in Blue for Celiac Disease Awareness
Milwaukee landmarks will be illuminated in blue on May 16th to raise awareness for Celiac Disease, a genetic autoimmune condition with no medical cure. Learn more about the Shine a Light on Celiac Disease campaign and resources available at the Celiac Disease Foundation and Beyond Celiac. Stay informed with daily headlines and breaking news from FOX6 News, covering a wide range of topics including local news, weather alerts, financial news, entertainment options, and more. Connect with FOX6 through social media platforms and access additional news coverage from FOX affiliates in Chicago, Minneapolis, and Detroit.
Rheumatoid Arthritis Drug Abatacept May Also Prevent the Disease
Rheumatoid arthritis drug abatacept, already used to treat the disease, may also prevent its onset, new research shows. Clinical trial results published in The Lancet indicate that abatacept eases symptoms and prevents joint damage, offering hope to the 1.3 million Americans living with the painful inflammatory disease.